200
Participants
Start Date
November 23, 2023
Primary Completion Date
November 27, 2024
Study Completion Date
February 11, 2025
Moxidectin Oral Product
The required number of moxidectin 2 mg tablet over encapsulated capsules will be administered as a single dose with placebo capsules to match as required
Moxidectin Oral Product
The required number of moxidectin 2 mg tablet over encapsulated capsules will be administered as a single dose with placebo capsules to match as required
Moxidectin Oral Product
The required number of moxidectin 2 mg tablet over encapsulated capsules will be administered as a single dose.
Placebo
16 placebo capsules will be administered as a single dose.
Derclinic, San Pedro Sula
Hospital y Clinica Bendana, San Pedro Sula
Evolution Clinical Trials, Miami
Advanced Care and Clinical Trials, LLC, Miami
Medical Research of Westchester, Inc, Miami
Affinity Clinical Research LLC, Tampa
LA Universal Research Center, Inc, Los Angeles
Instituto Dermatologico Dominicano y Cirugia de Piel, Santo Domingo Oeste
Vargas Clinic, San Salvador
Medicines Development for Global Health
OTHER